Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1613-2024Class I

Route 92 Medical, Tenzing 7 Delivery Catheter, REF 1005, Rx Only, Sterile EO. Used for introduction of...

Route 92 Medical, Head Quarters / initiated 2024-03-08 / Open, Classified / root cause: manufacturing process

ROUTE 92 MEDICAL INC began a recall of Route 92 Medical, Tenzing 7 Delivery Catheter, REF 1005, Rx Only, Sterile EO. Used for introduction of interventional devices into the neurovasculature on . FDA classified it as Class I and gives the reason as "Their is the potential for distal tip separation at the proximal marker band of the delivery catheters". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-1613-2024
Classification
Class I
Status
Open, Classified
Initiated
Posted
Recalling firm
Route 92 Medical, Head Quarters
Product
Route 92 Medical, Tenzing 7 Delivery Catheter, REF 1005, Rx Only, Sterile EO. Used for introduction of interventional devices into the neurovasculature.
Product code
DQY Catheter, Percutaneous
Reason for recall
Their is the potential for distal tip separation at the proximal marker band of the delivery catheters
Root cause tag
manufacturing process
FDA root cause
Process control
Action
On March 12, 2024 Route 92, issued a Urgent Medical Device recall notification to affected consignees via Mail and EMail. Route 92 asked consignees to take the following actions: Ensure all of your SUMMIT MAX inventory including the affected 070 Reperfusion Systems is in a secure, quarantined location. 2. Complete the Acknowledgement Form in Attachment 2 and return to Route 92 Medical by one of the following methods: [email protected]/Standard Mail - Attention Line: Tenzing 7 fiedl action, 155 Bovet Road Suite 100, San Mateo, CA 94402 Please return the Acknowledgement Form even if you no longer have the product subject to this recall. 4. Immediately return any affected products with the specific lot numbers listed in Attachment 1 to the address above using the original shipping container or request a new shipping container and pre-printed shipping label by email. 5. Keep this notice until all product subject to this recall has been returned. While processing your returns, please maintain a copy of this notice with the quarantined product subject to this recall and keep a copy for your records. 6. Separately, as part of SUMMIT MAX closure, you will be sending back your remaining SUMMIT MAX inventory if you haven t done so already.
Quantity in commerce
200 units
Distribution
US: AL AZ CA DE FL GA IA IL IN KY LA MA MD MI MN MO NC ND NJ NY OH OR PA RI SD TN TX UT VA WV OUS: New Zealand
Product codes and lots
UDI: 00853799007534/ Lot # 23033001, 23073101, 23070305, 23081707

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1613-2024
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1610-2024Class IOngoingVoluntary: Firm initiated
Z-1611-2024Class IOngoingVoluntary: Firm initiated
Z-1612-2024Class IOngoingVoluntary: Firm initiated
Z-1613-2024Class IOngoingVoluntary: Firm initiated
Z-1614-2024Class IOngoingVoluntary: Firm initiated